World's Best Scientists 2026 revealed!
John C. Burnett

John C. Burnett

D-Index & Metrics

Medicine

D-Index
126
Citations
58722
World Ranking
2960
National Ranking
1640

Overview

John C. Burnett is affiliated with the Mayo Clinic in the United States and has a substantial body of research primarily focused on medicine, with an emphasis on cardiology and cardiovascular medicine. Their work spans multiple related subfields including molecular biology, endocrinology, diabetes and metabolism, pulmonary and respiratory medicine, and physiology.

The scientist's research covers several interconnected topics, notably heart failure treatment and management, cardiovascular function and risk factors, receptor mechanisms and signaling, renin-angiotensin system studies, phosphodiesterase function and regulation, potassium and related disorders, as well as blood pressure and hypertension studies.

Burnett has published papers in various well-known medical journals, with frequent contributions appearing in:

  • Journal of the American College of Cardiology
  • Circulation
  • Journal of Cardiac Failure
  • Hypertension
  • JACC Heart Failure

Key recent papers include:

  • THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors, 2021, British Journal of Pharmacology
  • The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors, 2023, British Journal of Pharmacology
  • Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction, 2020, JAMA
  • Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction, 2020, JACC Heart Failure
  • Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature, 2020, British Journal of Pharmacology

Burnett's research collaboration network includes frequent coauthors such as Seethalakshmi Iyer, Jeson Sangaralingham, S. Jeson Sangaralingham, Valentina Cannone, and Shawn Reginauld.

Best Publications

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

  • Plasma brain natriuretic peptide concentration: impact of age and gender.

    Margaret M Redfield;Richard J Rodeheffer;Steven J Jacobsen;Douglas W Mahoney

  • Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.

    Amir Lerman;Brooks S. Edwards;John W. Hallett;Denise M. Heublein

  • Atrial Natriuretic Peptide Elevation in Congestive Heart Failure in the Human

    JC Burnett;PC Kao;DC Hu;DW Heser

  • Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials.

    Mihai Gheorghiade;Marvin A. Konstam;John C. Burnett;Liliana Grinfeld

  • The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy

    Virginia V. Michels;Patricia P. Moll;Fletcher A. Miller;A. Jamil Tajik

  • Endothelin in human congestive heart failure.

    Chi Ming Wei;Amir Lerman;Richard J. Rodeheffer;Christopher G.A. McGregor

  • Effects of synthetic atrial natriuretic factor on renal function and renin release

    J. C. Burnett;J. P. Granger;T. J. Opgenorth

  • Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

    Kazuhiro Yamamoto;John C. Burnett;Michihisa Jougasaki;Rick A. Nishimura

  • Progression of left ventricular diastolic dysfunction and risk of heart failure.

    Garvan C. Kane;Barry L. Karon;Douglas W. Mahoney;Margaret M. Redfield

  • Consensus recommendations for the management of chronic heart failure: Introduction

    Milton Packer;Jay N. Cohn;William T. Abraham;Wilson S. Colucci

  • Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial

    Andrew P. Ambrosy;Peter S. Pang;Sadiya Khan;Marvin A. Konstam

  • Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor.

    B S Edwards;R S Zimmerman;T R Schwab;D M Heublein

  • Natriuretic peptide system in human heart failure.

    Chi Ming Wei;Denise M. Heublein;Mark A. Perrella;Amir Lerman

  • Prevalence and prognostic significance of heart failure stages: Application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community

    Khawaja Afzal Ammar;Steven J. Jacobsen;Douglas W. Mahoney;Jan A. Kors

  • Long-term l-Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans

    Amir Lerman;John C. Burnett;Stuart T. Higano;Linda J. McKinley

  • Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community Determinants and Detection of Left Ventricular Dysfunction

    Lisa C. Costello-Boerrigter;Guido Boerrigter;Margaret M. Redfield;Richard J. Rodeheffer

  • Elevation of Circulating and Ventricular Adrenomedullin in Human Congestive Heart Failure

    Michihisa Jougasaki;Chi Ming Wei;Linda J. McKinley;John C. Burnett

  • Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment

    Mihai Gheorghiade;Gerasimos Filippatos;Leonardo De Luca;John Burnett

  • Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure

    Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld

Frequent Co-Authors

Kent R. Bailey
Kent R. Bailey Mayo Clinic
Amir Lerman
Amir Lerman Mayo Clinic
Mihai Gheorghiade
Mihai Gheorghiade Northwestern University
Marvin A. Konstam
Marvin A. Konstam Tufts Medical Center
James E. Udelson
James E. Udelson Tufts Medical Center
Kenneth B. Margulies
Kenneth B. Margulies University of Pennsylvania
Karl Swedberg
Karl Swedberg University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in Medicine doesn’t always mean following the traditional path. Today, many students are exploring flexible and budget-friendly options, such as the affordable online fnp programs, which allow you to become a Family Nurse Practitioner and play an advanced role in patient care.

For those starting their nursing journey, there are numerous cheap online nursing programs. These programs offer solid foundations in nursing practice and can often be completed more quickly than traditional degrees.

Experienced RNs looking to advance their qualifications may consider the cheapest online rn to bsn programs, which provide an affordable way to earn a Bachelor of Science in Nursing and open up leadership opportunities.

Aspiring nurse educators or researchers might look into the cheapest phd nursing programs. These online options make it easier to pursue advanced research and academic roles without foregoing your current career.

Exploring these related online degrees can help you find the healthcare pathway that fits your goals, lifestyle, and budget.

Best Scientists Citing John C. Burnett

Trending Scientists